市場調查報告書
商品編碼
1028234

血液培養檢驗市場:現狀分析與預測(2021年∼2027年)

Blood Culture Tests Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

血液培養檢驗,是為了檢測血液中是否存在細菌或真菌等微生物。用於確定感染的存在,識別病原體並指導患者所需的適當治療。由於敗血症病例數量增加、老年人口增加、傳染病的高患病率以及血流感染的高發率,推動了該市場的成長。例如,在全球範圍內,血液感染影響約3000萬人,導致600萬人死亡,每年有300萬新生兒和120萬兒童患有敗血症。

本報告提供全球血液培養檢驗市場調查,市場概要,各培養方法、技術、用途、終端用戶、地區的詳細趨勢,新型冠狀病毒感染疾病(COVID-19)的影響,收益趨勢,市場成長要素及課題,市場機會,價值鏈分析,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 簡介

  • 市場定義
  • 調查的目的
  • 限制
  • 相關利益者
  • 使用貨幣
  • 調查範圍

第2章 調查手法、前提條件

第3章 市場概要

第4章 摘要整理

第5章 COVID-19期間的血液培養檢驗市場

第6章 全球血液培養檢驗市場收益額(2019年∼2027年)

第7章 全球血液培養檢驗市場洞察:各產品

  • 消耗品
    • 媒體
    • 化驗套件、試劑
  • 設備
    • 自動血液培養系統
    • 實驗室支援設備
  • 軟體、服務

第8章 全球血液培養檢驗市場洞察:各培養方法

  • 傳統/手動
  • 自動

第9章 全球血液培養檢驗市場洞察:各技術

  • 培養技術
  • 分子技術
  • 蛋白質體學技術

第10章 全球血液培養檢驗市場洞察:各用途

  • 菌血症
  • 真正菌血症
  • 分枝桿菌檢測

第11章 全球血液培養檢驗市場洞察:各終端用戶

  • 醫院實驗室
  • 索引實驗室
  • 學術研究機關
  • 其他

第12章 全球血液培養檢驗市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 其他
  • 其他地區

第13章 市場動態

  • 市場成長要素
  • 市場課題
  • 影響分析

第14章 市場機會

第15章 市場趨勢

第16章 相關法規

第17章 需求與供給側面分析

  • 需求面分析
  • 供給側面分析
    • 主要產品的銷售
    • 商務夥伴關係
    • 事業擴大、投資、出售
    • 合併、收購

第18章 價值鏈分析

第19章 競爭模式

  • 波特的五力分析
    • 賣主談判力
    • 買方議價能力
    • 競爭企業間的敵對關係
    • 替代品的威脅
    • 新加入業者的威脅
  • 競爭情形

第20章 企業概要

  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • bioMerieux SA
  • Luminex Corporation
  • Danaher Corporation
  • Bruker Corporation
  • IRIDICA
  • Roche Diagnostics
  • T2 Biosystems, Inc.
  • Anaerobe Systems, Inc

第21章 免責聲明

目錄
Product Code: UMHE21361

Blood culture tests are done to detect the presence of microorganisms such as bacteria or fungi in the blood. It is used to determine the presence of infection, identify the causative agents and to guide the proper treatment required to a patient. Blood culture testing is used to identify a blood infection (also called septicemia) which if otherwise left undetected can lead to a serious and fatal condition called sepsis. The symptoms of an initial bacterial infection or bacteremia are moderate or high fever, chills, breathlessness, tachycardia, muscular pain, palpitations, nausea, and headache.

Although blood samples can be used for the detection of virus in the blood, blood culture is generally used to detect bacteria and fungi. Blood culture test is often done in conjunction with other diagnostic tests such as complete blood count (CBC) or other chemical analysis. A variety of technique such as conventional/manual, semi-automated and automated methods can be used to perform blood culture test.

The growth of this market is driven owing to increasing number of sepsis cases, rising geriatric population, high prevalence of infectious diseases, and high incidence of bloodstream infections. For instance, Globally, bloodstream infections affect about 30 million people leading to 6 million deaths, with 3 million newborns and 1.2 million children suffering from sepsis annually. In Eastern African countries, the proportion of patients with bloodstream infections is reported to range from 11% to 28%. In Ghana, bloodstream infection rates are estimated to be in the range of 9.3% to 11.2%. The occurrence of these infections increases the overall duration of hospitalization as well as the cost of treatment.

Based on product, the global blood culture tests market is segmented into consumables, instruments, and software and services. Currently, consumables segment is expected to dominate the market by holding largest market share during the forecast period which cab be ascribed to the recurring requirement of consumables as compared to instruments.

In terms of method, the market is categorized into conventional/manual blood culture and automated blood culture methods. In 2020, the conventional/manual blood culture segment held the largest market share in 2020 due to its extensive use in independent clinical laboratories and increase in application of this conventional blood culture method in hospitals & pathology laboratories. However, the automated blood culture methods segment is expected to register the highest CAGR during the forecast period. The quick turnaround time and reduced risk of contamination due to low manual intervention are the key factors contributing to market growth.

By technology, the global blood culture tests market is segmented into culture-based, molecular, and proteomic. In 2020, culture-based technology segment held the largest market share in terms of revenue. This is due to high usage of this technology by various laboratories such as hospital, reference, pathology, and physician office laboratories.

In terms of application, the blood culture tests market is segmented into bacteremia, fungemia, and mycobacterial detection. Among them, bacteremia accounted for the largest market share in 2020 and is further projected to maintain its leading position during the forecast period as well. The large share of this segment is primarily attributed to the increasing number of bloodstream infections and the growing number of sepsis cases worldwide.

Based on end-user the market is categorized into hospital laboratories, reference laboratories, academic research laboratories, others. Hospital laboratories accounted for the largest market share in terms of revenue. This is owing to the increasing incidence of Hospital-acquired Infections (HAIs). According to the WHO, the rate of ICU-acquired infections, including Urinary Tract Infections (UTIs) and surgical-site wound infections, is around two to three times higher in developing countries as compared to developed countries. In Canada, about 8,000 patients die annually because of hospital-acquired infections.

For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC), and Rest of World. North America has dominated the Blood Culture Tests Market which is attributable to rise in prevalence of bloodstream infection and presence of advanced healthcare infrastructure. Furthermore, rise in awareness & acceptance of novel diagnostic method, strong economic growth, and increase in demand for advanced healthcare facilities are contributing toward growth of the market.

Some of the major players operating in the market include Becton Dickinson and Company, Thermo Fisher Scientific, Inc., bioMerieux SA, Luminex Corporation, Danaher Corporation, Bruker Corporation, IRIDICA, Roche Diagnostics, T2 Biosystems, Inc, Anaerobe Systems, Inc.

TABLE OF CONTENTS

1.       MARKET INTRODUCTION

  • 1.1.    Market Definitions
  • 1.2.    Objective of the Study
  • 1.3.    Limitation
  • 1.4.    Stake Holders
  • 1.5.    Currency Used in Report
  • 1.6.    Scope of the Blood Culture Tests Market Study

2.       RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1.    Research Methodology for the Global Blood Culture Tests Market
    • 2.1.1.Main Objective of the Global Blood Culture Tests Market

3.       MARKET SYNOPSIS

4.       EXECUTIVE SUMMARY

5.       BLOOD CULTURE TESTS AMID COVID-19

6.       GLOBAL BLOOD CULTURE TESTS MARKET REVENUE (USD MN), 2019-2027F

7.       MARKET INSIGHTS BY PRODUCT

  • 7.1.    Consumables
    • 7.1.1. Blood Culture Media
    • 7.1.2. Assay Kits & Reagents
    • 7.1.3. Automated Methods
  • 7.2.    Instruments
    • 7.2.1.  Automated Blood Culture Systems
    • 7.2.2. Supporting Laboratory Equipment
  • 7.3.     Software and Services

8.       MARKET INSIGHTS BY METHOD

  • 8.1.    Conventional/ Manual Methods
  • 8.2.    Automated Methods

9.       MARKET INSIGHTS BY TECHNOLOGY

  • 9.1.    Culture-Based Technology
  • 9.2.    Molecular Technologies
  • 9.3.    Proteomics Technology

10.   MARKET INSIGHTS BY APPLICATION

  • 10.1.                     Bacteremia
  • 10.2.                     Fungemia
  • 10.3.                     Mycobacterial Detection

11.   MARKET INSIGHTS BY END-USER

  • 11.1.                     Hospital Laboratories
  • 11.2.                     Reference Laboratories
  • 11.3.                     Academic Research Laboratories
  • 11.4.                     Others

12.   MARKET INSIGHTS BY REGION

  • 12.1.                     North America Blood Culture Tests Market
    • 12.1.1.    United States
    • 12.1.2.    Canada
    • 12.1.3.    Rest of North America
  • 12.2.                     Europe Blood Culture Tests Market
    • 12.2.1.    Germany
    • 12.2.2.    France
    • 12.2.3.    United Kingdom
    • 12.2.4.    Italy
    • 12.2.5.    Spain
    • 12.2.6.    Rest of Europe
  • 12.3.                     Asia Pacific Blood Culture Tests Market
    • 12.3.1.    China
    • 12.3.2.    Japan
    • 12.3.3.    India
    • 12.3.4.    South Korea
    • 12.3.5.    Rest of Asia Pacific
  • 12.4.                     Rest of World Blood Culture Tests Market

13.   BLOOD CULTURE TESTS MARKET DYNAMICS

  • 13.1.                     Market Drivers
  • 13.2.                     Market Challenges
  • 13.3.                     Impact Analysis

14.   BLOOD CULTURE TESTS MARKET OPPORTUNITIES

15.   BLOOD CULTURE TESTS MARKET TRENDS

16.   LEGAL & REGULATORY FRAMEWORK

17.   DEMAND AND SUPPLY SIDE ANALYSIS

  • 17.1.                     Demand Side Analysis
  • 17.2.                     Supply Side Analysis
    • 17.2.1.    Top Product Launches
    • 17.2.2.    Top Business Partnerships
    • 17.2.3.    Top Business Expansions, Investments and Divestitures
    • 17.2.4.    Top Merger and Acquisitions

18.   VALUE CHAIN ANALYSIS

19.   COMPETITIVE SCENARIO

  • 19.1.                     Porter's Five Forces Analysis
    • 19.1.1.    Bargaining power of Supplier
    • 19.1.2.    Bargaining power of Buyer
    • 19.1.3.    Industry Rivalry
    • 19.1.4.    Availability of Substitute
    • 19.1.5.    Threat of new Entrants
  • 19.2.                     Competitive Landscape
    • 19.2.1.    Company Shares, By Revenue

20.   COMPANY PROFILED

  • 20.1.                     Becton, Dickinson and Company
  • 20.2.                     Thermo Fisher Scientific, Inc.
  • 20.3.                     bioMerieux SA
  • 20.4.                     Luminex Corporation
  • 20.5.                     Danaher Corporation
  • 20.6.                     Bruker Corporation
  • 20.7.                     IRIDICA
  • 20.8.                     Roche Diagnostics
  • 20.9.                     T2 Biosystems, Inc.
  • 20.10.                  Anaerobe Systems, Inc.

21.   DISCLAIMER